Search - tctmd.com

Displaying 101 - 119 of 119

Presentation TCT 2012

Safety and Efficacy of the Xience Everolimus Eluting Stent Compared to First-Generation Drug-Eluting Stents in Contemporary Clinical Practice.

Presenter: Israel M. Barbash, Rebecca Torgusson, Itsik Ben-Dor, Gabriel Maluenda, Zhenyi Xue, William O. Suddath, Lowell F. Satler, Kenneth M. Kent, Augusto D. Pichard, Ron Waksman

January 03, 2012

Presentation TCT 2012

Safety and Effectiveness of Everolimus-Eluting Stents in 5054 Patients from a Large, Prospective, Real World Study: Two-Year Clinical Outcomes from the XIENCE V® USA Study.

Presenter: Mitchell W. Krucoff, David R. Rutledge, Vivian W. Mao, Weiying Zhao, Alena V. Pechonkina, Jin Wang, Lalitha K. Jonnavithula, Krishnankutty Sudhir, James B. Hermiller

January 03, 2012

Presentation TCT 2012

Prospective Evaluation Of the Xience V Everolimus-Eluting Stent In Saphenous Vein Graft Atherosclerosis: the Xience V-SVG Angiographic Study.

Presenter: Emmanouil S. Brilakis, Aristotelis C. Papayannis, Abdul-rahman R. Abdel-karim, Tesfaldet T. Michael, Arif Mahmood, Lorenza B. Makke, Michele Roesle, Donald Haagen, Bavana V. Rangan, Subhash Banerjee

January 03, 2012

Presentation TCT 2012

Microarray Analysis for Nobori Biolimus A9 Eluting Stent and Xience V Everolimus Eluting Stent in Porcine Coronary Artery

Presenter: Arihiro Sumida, Selvamuthu Natarajan, Deepal Panchal, Jinsheng Li, Dongming Hou, Nicholas Chronos, Jaipal Singh, Surendra Chavan

January 03, 2012

Presentation TCT 2012

Healing Responses After Bifurcation Stenting with the Dedicated TRYTON Side-Branch Stent in Combination with XIENCE V Stents: an Angiography and Optical Coherence Tomography Study.

Presenter: Christophe L. Dubois, Tom Adriaenssens, Giovanni Ughi, Mark Coosemans, Bert Ferdinande, Peter Sinnaeve, Walter Desmet

January 03, 2012

Presentation TCT 2012

An All Comers Randomized Trial Comparing Xience Prime and Promus Element Stents. Preliminary Results.

Presenter: Jose M. De la Torre Hernandez, Tamara Garcia Camarero, Piedad Lerena, Dae-Hyun Lee, Fermin Sainz Laso, Virginia Frances Santamaria, Monica Fernandez Menendez, Gonzalo Martin Gorria, Javier Zueco

January 03, 2012

News Conference News

TWENTE: Zotarolimus DES Noninferior to Everolimus DES at 1 Year

L.A. McKeown

November 28, 2011

News Conference News

Advertisement

Safety and Efficacy of the Xience Everolimus Eluting Stent Compared to First-Generation Drug-Eluting Stents in Contemporary Clinical Practice.

Safety and Effectiveness of Everolimus-Eluting Stents in 5054 Patients from a Large, Prospective, Real World Study: Two-Year Clinical Outcomes from the XIENCE V® USA Study.

Prospective Evaluation Of the Xience V Everolimus-Eluting Stent In Saphenous Vein Graft Atherosclerosis: the Xience V-SVG Angiographic Study.

Microarray Analysis for Nobori Biolimus A9 Eluting Stent and Xience V Everolimus Eluting Stent in Porcine Coronary Artery

Healing Responses After Bifurcation Stenting with the Dedicated TRYTON Side-Branch Stent in Combination with XIENCE V Stents: an Angiography and Optical Coherence Tomography Study.

An All Comers Randomized Trial Comparing Xience Prime and Promus Element Stents. Preliminary Results.

TWENTE: Zotarolimus DES Noninferior to Everolimus DES at 1 Year

RAPID GENE: Validation of Point-of-Care Genetic Testing

ZES and SES Equally Effective in Long Lesion Treatment

SPIRIT PRIME: EES Efficacy ‘Similar and Consistent’ with Xience V Technology

Safety, Efficacy Reported with FIREHAWK SES

Preclinical Results Promising for Combo Stent

Low Event Rates with EES Sustained at 2 Years

EES Compared Favorably with SES In Two Pivotal Trials

Bioabsorbable Polymers, Scaffolds Offer Permanent Advantages

ZES, EES Noninferior to PES

EES Associated with Reduced MACE Compared with SES

Early Discontinuation of DAPT May Increase Risk of Stent Thrombosis

DES Noninferior for Survival Compared with BMS in STEMI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content